ArticleJAMA oncology2019

Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Zachary R McCaw et al.PubMed ↗Publisher ↗

No numbers read from the abstract.